Latest filing published 10 Apr 2026 for Ginkgo Bioworks Holdings, Inc., €577k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jason R. Kelly on record concern Ginkgo Bioworks Holdings, Inc. Over a trading history stretching from 6 December 2021 to 9 April 2026, the count stands at 94 filings.
Every open-market trade on record is a sale: 90 sales worth €22.2M. The rest of the record consists of 3 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The newest entry dates from 10 April 2026: an open-market sale of €577k, in Ginkgo Bioworks Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 94 declarations